Cancer Letters
Volume 294, Issue 2 , Pages 254-263 , 28 August 2010

GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling

  • Ji Seung Choi

      Affiliations

    • Carcinogenesis Branch, Div. of Cancer Biology, National Cancer Center, Research Institute, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi 410-769, South Korea
    • ,
  • A Rome Paek

      Affiliations

    • Carcinogenesis Branch, Div. of Cancer Biology, National Cancer Center, Research Institute, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi 410-769, South Korea
    • ,
  • Soo Youl Kim

      Affiliations

    • Cancer Cell and Molecular Biology Branch, Div. of Cancer Biology, National Cancer Center, Research Institute, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi 410-769, South Korea
    • ,
  • Hye Jin You

      Affiliations

    • Carcinogenesis Branch, Div. of Cancer Biology, National Cancer Center, Research Institute, 111 Jungbalsan-ro, Ilsandong-gu, Goyang, Gyeonggi 410-769, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 31 920 2206; fax: +82 31 920 2218.

Received 29 September 2009 ,Revised 9 February 2010 ,Accepted 10 February 2010.

References 

  1. LeRoith D, Roberts CT. The insulin-like growth factor system and cancer. Cancer Lett. 2003;195:127–137
  2. Miller BS, Yee D. Type I insulin-like growth factor receptor as a therapeutic target in cancer. Cancer Res. 2005;65:10123–10127
  3. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat. Rev. Cancer. 2008;8:915–928
  4. Rodon J, DeSantos V, Ferry RJ, Kurzrock R. Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: lessons from the first clinical trials. Mol. Cancer Ther. 2008;7:2575–2588
  5. Tao Y, Pinzi V, Bourhis J, Deutsch E. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway – therapeutic perspectives in cancer. Nat. Clin. Pract. Oncol. 2007;4:591–602
  6. Ouban A, Muraca P, Yeatman T, Coppola D. Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas. Hum. Pathol. 2003;34:803–808
  7. Liu W, Bloom DA, Cance WG, Kurenova EV, Golubovskaya VM, Hochwald SN. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells. Carcinogenesis. 2008;29:1096–1107
  8. Watanabe N, Takaoka M, Sakurama K, Tomono Y, Hatakeyama S, Ohmori O, et al. Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits anticancer effect in esophageal adenocarcinoma in vitro and in vivo. Clin. Cancer Res. 2008;14:4631–4639
  9. Ligensa T, Krauss S, Demuth D, Schumacher R, Camonis J, Jaques G, et al. A PDZ domain protein interacts with the C-terminal tail of the insulin-like growth factor-1 receptor but not with the insulin receptor. J. Biol. Chem. 2001;276:33419–33427
  10. Booth RA, Cummings C, Tiberi M, Liu XJ. GIPC participates in G protein signaling downstream of insulin-like growth factor 1 receptor. J. Biol. Chem. 2002;277:6719–6725
  11. Muders MH, Dutta SK, Wang L, Lau JS, Bhattacharya R, Smyrk TC, et al. Expression and regulatory role of GAIP-interacting protein GIPC in pancreatic adenocarcinoma. Cancer Res. 2006;66:10264–10268
  12. Blobe GC, Liu X, Fang SJ, How T, Lodish HF. A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC. J. Biol. Chem. 2001;276:39608–39617
  13. Favre-Bonvin A, Reynaud C, Kretz-Remy C, Jalinot P. Human papillomavirus type 18 E6 protein binds the cellular PDZ protein TIP-2/GIPC, which is involved in transforming growth factor beta signaling and triggers its degradation by the proteasome. J. Virol. 2005;79:4229–4237
  14. Chow JC, Condorelli G, Smith RJ. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway. J. Biol. Chem. 1998;273:4672–4680
  15. Girnita L, Shenoy SK, Sehat B, Vasilcanu R, Vasilcanu D, Girnita A, et al. Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression. J. Biol. Chem. 2007;282:11329–11338
  16. Kenchappa P, Yadav A, Singh G, Nandana S, Banerjee K. Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases. J. Neurosci. Res. 2004;76:466–474
  17. Xu P, Jacobs AR, Taylor SI. Interaction of insulin receptor substrate 3 with insulin receptor, insulin receptor-related receptor, insulin-like growth factor-1 receptor, and downstream signaling proteins. J. Biol. Chem. 1999;274:15262–15270
  18. Meng D, Lv DD, Fang J. Insulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cells. Cardiovasc. Res. 2008;80:299–308
  19. Vardatsikos G, Sahu A, Srivastava A. The insulin-like growth factor family: molecular mechanisms redox, regulation and clinical implications. Antioxid. Redox Signal. 2009;
  20. You HJ, Lee JW, Yoo YJ, Kim JH. A pathway involving protein kinase Cdelta up-regulates cytosolic phospholipase A(2)alpha in airway epithelium. Biochem. Biophys. Res. Commun. 2004;321:657–664
  21. Dupont J, Le Roith D. Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol. Pathol. 2001;54:149–154
  22. Kurmasheva RT, Houghton PJ. IGF-I mediated survival pathways in normal and malignant cells. Biochim. Biophys. Acta. 2006;1766:1–22
  23. Larsson O, Girnita A, Girnita L. Role of insulin-like growth factor 1 receptor signalling in cancer. Br. J. Cancer. 2005;92:2097–2101
  24. Bustin SA, Jenkins PJ. The growth hormone–insulin-like growth factor-I axis and colorectal cancer. Trends Mol. Med. 2001;7:447–454
  25. Grimberg A, Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. J. Cell Physiol. 2000;183:1–9
  26. Montessuit C, Rosenblatt-Velin N, Papageorgiou I, Campos L, Pellieux C, Palma T, et al. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4. Cardiovasc. Res. 2004;64:94–104
  27. Parrizas M, Gazit A, Levitzki A, Wertheimer E, LeRoith D. Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins. Endocrinology. 1997;138:1427–1433
  28. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc. Natl. Acad. Sci. USA. 2004;101:2076–2081
  29. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, et al Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986;5:2503–2512
  30. Dalle S, Ricketts W, Imamura T, Vollenweider P, Olefsky JM. Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J. Biol. Chem. 2001;276:15688–15695
  31. Sehat B, Andersson S, Vasilcanu R, Girnita L, Larsson O. Role of ubiquitination in IGF-1 receptor signaling and degradation. PLoS ONE. 2007;2:e340
  32. Lee NY, Ray B, How T, Blobe GC. Endoglin promotes transforming growth factor beta-mediated Smad 1/5/8 signaling and inhibits endothelial cell migration through its association with GIPC. J. Biol. Chem. 2008;283:32527–32533
  33. Lahteenvuo JE, Lahteenvuo MT, Kivela A, Rosenlew C, Falkevall A, Klar J, et al. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation. 2009;119:845–856
  34. Wieman HL, Horn SR, Jacobs SR, Altman BJ, Kornbluth S, Rathmell JC. An essential role for the Glut1 PDZ-binding motif in growth factor regulation of Glut1 degradation and trafficking. Biochem. J. 2009;418:345–367
  35. El Mourabit H, Poinat P, Koster J, Sondermann H, Wixler V, Wegener E, et al. The PDZ domain of TIP-2/GIPC interacts with the C-terminus of the integrin alpha5 and alpha6 subunits. Matrix Biol. 2002;21:207–214
  36. Tani TT, Mercurio AM. PDZ interaction sites in integrin alpha subunits. T14853, TIP/GIPC binds to a type I recognition sequence in alpha 6A/alpha 5 and a novel sequence in alpha 6B. J. Biol. Chem. 2001;276:36535–36542
  37. Lou X, Yano H, Lee F, Chao MV, Farquhar MG. GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. Mol. Biol. Cell. 2001;12:615–627
  38. Rhee SG. Cell signaling. H2O2 a necessary evil for cell signaling. Science. 2006;312:1882–1883
  39. Rhee SG, Kang SW, Jeong W, Chang TS, Yang KS, Woo HA. Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins. Curr. Opin. Cell Biol. 2005;17:183–189
  40. Tonks NK. Redox redux: revisiting PTPs and the control of cell signaling. Cell. 2005;121:667–670
  41. Tonks NK. Protein tyrosine phosphatases: from genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 2006;7:833–846
  42. Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovasc. Res. 2006;71:226–235
  43. Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, et al. Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc. Natl. Acad. Sci. USA. 2008;105:7147–7152
  44. Woo CH, Kim TH, Choi JA, Ryu HC, Lee JE, You HJ, et al. Inhibition of receptor internalization attenuates the TNFalpha-induced ROS generation in non-phagocytic cells. Biochem. Biophys. Res. Commun. 2006;351:972–978

PII: S0304-3835(10)00095-9

doi: 10.1016/j.canlet.2010.02.007

Cancer Letters
Volume 294, Issue 2 , Pages 254-263 , 28 August 2010

Article Tools

* Image Usage & Resolution